Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02007863 · ClinicalTrials.gov registry record · NA
Umbilical Cord Blood (UCB) Transplantation in Pediatric Patients With High Risk Leukemia and Myelodysplasia
A NA study, sponsored by University of Miami.
- Completed
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT02007863 is a NA study that has completed, run by University of Miami. The registered enrollment target is 2 participants.
The verdict
NCT02007863, a NA study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
Unrelated Cord Blood (UCB) transplant in children is a viable stem cell transplant modality for patients with leukemia and myelodysplasia. UCB is now considered "Standard Of Care" in cases where a suitable living bone marrow donor is not available. The survival of UCB is similar to Matched Unrelated Marrow Transplant. This study is considered "Research" since UCB is not a licensed product and requires investigational new drug (IND). THERE ARE NO SPECIFIC RESEARCH QUESTIONS IN THIS PROTOCOL. This protocol merely provides UCB as a stem cell treatment modality to pediatric patients who may require it after a conditioning regimen that excludes Total Body Irradiation.
Interventions
- DRUG Fludarabine
- DRUG Melphalan
- DRUG Busulfan
- PROCEDURE Umbilical Cord Blood Transfusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2008-08 |
| Est. Completion | 2014-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02007863
The ClinicalTrials.gov registry entry for NCT02007863 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Fludarabine is the first listed.
NCT02007863 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02007863 about?
NCT02007863 is a clinical study titled "Umbilical Cord Blood (UCB) Transplantation in Pediatric Patients With High Risk Leukemia and Myelodysplasia". Unrelated Cord Blood (UCB) transplant in children is a viable stem cell transplant modality for patients with leukemia and myelodysplasia. UCB is now considered "Standard Of Care" in cases where a suitable living bone marrow donor is not available. The survival of UCB is similar to Matched Unrelated...
What is the current status of trial NCT02007863?
This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2008-08. Estimated completion is 2014-06.
What interventions are being tested in trial NCT02007863?
The interventions under investigation include: Fludarabine (DRUG), Melphalan (DRUG), Busulfan (DRUG), Umbilical Cord Blood Transfusion (PROCEDURE).
Who is sponsoring clinical trial NCT02007863?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.